drugset / Trial / NCT00398892

The Effects of Lipoic Acid on Glycaemic Control in Type 2 Diabetes

NCT00398892

RandomizedCrossoverTriple-blindTreatment

Summary

Hypothesis: that lipoic acid supplements taken orally will improve control of blood sugar levels in people with type 2 diabetes. This study will recruit 18 people with type 2 diabetes, whose diabetes is currently managed on oral agents. Each subject will then either take placebo for 12 weeks followed by lipoic acid for 12 weeks, or lipoic acid followed by placebo. A blood test for overall diabetes control will be taken at the start and end of each 12 week period, and the change in control will be compared for lipoic acid vs placebo.

Timeline

Start
2009-12
Primary completion
2011-01
Completion
2011-01

Drugs

EvaluationDrugModalityDoseRoute
Subject alpha-lipoic acid Small molecule 600 mg Oral